The New TNM Staging System for Thyroid Cancer and the Risk of Disease Downstaging
In October 2016 the American Joint Committee on Cancer (AJCC) published the 8th edition of the AJCC/TNM cancer staging system and it has been introduced in clinical practice since 1st January 2018. The effect of most of the changes in the new edition was the downstaging of a significant number of pa...
Main Authors: | Claudio Casella, Silvia Ministrini, Alessandro Galani, Francesco Mastriale, Carlo Cappelli, Nazario Portolani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00541/full |
Similar Items
-
Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System
by: Zeming Liu, et al.
Published: (2019-10-01) -
Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort
by: Carla Fernanda Nava, et al. -
Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer
by: Wenjie Gong, et al. -
Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
by: Naoyoshi Onoda, et al.
Published: (2020-02-01) -
The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
by: Alina Wilkowska, et al.
Published: (2022-11-01)